カワニシホールディングス 2019年6月期第2四半期業績報告
https://www.olba.co.jp/ir/upload_file/m004-m004_01/20190221report.pdfThe evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
カワニシホールディングス 2019年6月期第2四半期業績報告
This document presents the performance report for the second quarter of the fiscal year ending June 2019 for Kawanishi Holdings. The consolidated sales reached 54.381 billion yen, maintaining a year-on-year growth of 100%, while operating profit decreased to 579 million yen, reflecting an 18% decline. The medical equipment business remains the primary revenue source, with steady performance in the Chugoku region, although other regions showed some weakness. Future strategies focus on new market development and improving profitability, addressing challenges such as the increasing import surplus in the medical device market and ongoing healthcare cost control measures. The document also highlights the need for operational efficiency and the acquisition of new revenue sources.